Distinguished Fellow Ivy Carroll to Receive Alfred Burger Award

RESEARCH TRIANGLE PARK, N.C. — Ivy Carroll, Ph.D., an RTI International distinguished fellow, was selected as the 2012 recipient of the Alfred Burger Award in Medicinal Chemistry sponsored by GlaxoSmithKline.

Carroll was selected for his numerous significant contributions to organic chemistry and drug discovery and development research. He will receive the award at the American Chemical Society National Meeting in March.

The Alfred Burger Award was established in 1978 to recognize outstanding contributions to research in medicinal chemistry and is granted bi-annually.

Carroll is an internationally recognized organic and medicinal chemist with more than 50 years of scientific leadership and accomplishment at RTI. He has made major scientific contributions in drug discovery and development, as well as in other research areas. Among his most recognized scientific contributions is the development of compounds as potential treatments for cocaine addiction, nicotine addiction and other central nervous system disorders.

Carroll is the recipient of numerous prestigious awards and honors including the North Carolina Award in Science in 2010, the 2002 Medicinal Chemistry Award from the American Chemical Society, the 2001 Herty Award, the 2000 Southern Chemist Award, the 1993 Distinguished Lecturer Award from the North Carolina section of the American Chemical Society, and the College on Problems of Drug Dependence 2006 Nathan B. Eddy Award. In addition, he was honored by the National Institute on Drug Abuse with the 1993 Pacesetter Award and the 2010 National Institute on Drug Abuse Public Service Award for Significant Achievement. In 2007, he was inducted into the American Chemical Society Medicinal Chemistry Hall of Fame.

Carroll holds a B.S. in chemistry from Auburn University and a Ph.D. in chemistry from the University of North Carolina at Chapel Hill. He has published 441 peer-reviewed publications, 34 book chapters and 43 patents and as well as several current patent applications in the fields of organic synthesis, medicinal chemistry, biochemistry and drug abuse research.